181
Participants
Start Date
July 7, 2014
Primary Completion Date
November 7, 2019
Study Completion Date
November 7, 2019
Ibrutinib
Participants will receive 420 mg of Ibrutinib orally.
Placebo
Participants will receive placebo capsules orally.
Rituximab
Participants will receive rituximab 375 mg/m\^2 IV.
Concord Repartriation General Hospital, Concord
The Canberra Hospital, Garran
Peter MacCallum Cancer Center, Melbourne
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medical Center, New York
Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin
Laiko General Hospital of Athens, Athens
Alexandra Hospital, Athens
Institut Paoli-Calmettes, Marseille
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan
ASST Grande Ospedale Metropolitano Niguarda, Milan
Centre Hospitalier de Saint Brieuc Hopital Yves le Foll, Saint-Brieuc
University General Hospital of Patras, Pátrai
ASST di Pavia - Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia
Hospital Universitario Infanta Leonor, Madrid
DIAKO Evangelische Diakonie Krankenhaus gGmbH, Bremen
Emory University Hospital, Atlanta
Azienda Ospedaliero Universitaria Santa Maria della Misericordia di Udine, Udine
Hospital Universitario de Salamanca, Salamanca
Vanderbilt University Medical Center, Nashville
Hôtel Dieu, Nantes
CHU de Nancy-Hopital Brabois Adulte, Vandœuvre-lès-Nancy
"University General Hospital of Thessaloniki AHEPA", Thessaloniki
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz
Hôpital Claude Huriez, Lille
Northwestern Memorial Hospital, Chicago
CHU Estaing, Clermont-Ferrand
Universität Des Saarlandes, Homburg
Centre Hospitalier Lyon Sud, Pierre-Bénite
Stauferklinikum Schwäbisch Gmünd, Mutlangen
Hôpital Saint Louis, Paris
Colorado Blood Cancer Institute, Denver
LMU Klinikum der Universität München, München
University of California Los Angeles, Los Angeles
Hopital Henri Mondor, Créteil
Stanford Cancer Center, Palo Alto
Dana Farber Cancer Institute, Boston
Hackensack University Medical Center, Hackensack
Flinders Medical Center, Bedford Park
Cross Cancer Institute, Edmonton
Queen Elizabeth II Health Sciences Center, Halifax
Princess Margaret Hospital, Toronto
McGill University Health Center, Montreal
Groupe Hospitalier Pitié Salpétrière, Paris
Hospital Universitari Germans Trias i Pujol, Badalona
Hospital Clinic de Barcelona, Barcelona
Hospital de La Santa Creu i Sant Pau, Barcelona
Royal Bournemouth Hospital, Bournemouth
Lead Sponsor
Janssen Research & Development, LLC
INDUSTRY
Pharmacyclics LLC.
INDUSTRY